Tag: Neuravi
Real-life use of EmboTrap shows comparable outcomes to large stroke studies
The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...
Cerenovus introduced at SNIS
Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...
Codman Neuro acquires Neuravi
Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...
Enrolment complete in ARISE II trial of EmboTrap device
Enrolment is now complete in the ARISE II clinical trial which is assessing the safety and effectiveness of the EmboTrap II revascularisation device (Neuravi),...
Neuravi secures €15 million to fund expansion
Neuravi has announced €15 million in venture debt financing from IPF Partners, a leading alternative financing provider focused on the healthcare sector.
This financing allows...
Neuravi announces European launch of EmboTrap II stent retriever for treatment...
Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...
